WO2014158641A1 - Preparation of haloalkoxyarylhydrazines and intermediates therefrom - Google Patents

Preparation of haloalkoxyarylhydrazines and intermediates therefrom Download PDF

Info

Publication number
WO2014158641A1
WO2014158641A1 PCT/US2014/018981 US2014018981W WO2014158641A1 WO 2014158641 A1 WO2014158641 A1 WO 2014158641A1 US 2014018981 W US2014018981 W US 2014018981W WO 2014158641 A1 WO2014158641 A1 WO 2014158641A1
Authority
WO
WIPO (PCT)
Prior art keywords
process according
formula
palladium
conducted
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2014/018981
Other languages
French (fr)
Inventor
Jr. Ronald ROSS
Peter BORROMEO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corteva Agriscience LLC
Original Assignee
Dow AgroSciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow AgroSciences LLC filed Critical Dow AgroSciences LLC
Publication of WO2014158641A1 publication Critical patent/WO2014158641A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C241/00Preparation of compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C241/02Preparation of hydrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72Hydrazones
    • C07C251/86Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of six-membered aromatic rings

Definitions

  • This document is related to the field of preparation of haloalkoxyarylhydrazines and intermediates therefrom, where said intermediates are useful in the preparation of certain pesticides.
  • U.S. Patent No. 8,178,658 discloses pesticidal compositions comprising a compound having the following structure:
  • alkyl as well as derivative terms such as “haloalkoxy”, as used herein, include within their scope straight chain, branched chain and cyclic moieties.
  • typical alkyl groups are methyl, ethyl, propyl, butyl, pentyl, hexyl, 1-methylethyl, 1,1-dimethylethyl, 1- methylpropyl, 2-methylpropyl, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
  • haloalkoxy includes alkoxy groups substituted with from one to the maximum possible number of halogen atoms, all combinations of halogens included. Unless specifically defined otherwise, the term “halogen” or “halo” includes fluorine, chlorine, bromine and iodine.
  • a haloalkoxyarylhalide of Formula 1 (wherein X is F, CI, Br, or I, preferably Br) is reacted with a hydrazone of Formula 1.1 to give an intermediate haloalkoxyarylhydrazone of Formula 1.2;
  • Ri and R 2 are independently aryl or heteroaryl, for example, phenyl, pyridyl, napthyl, and thienyl, substituted aryl or heteroaryl (wherein said substituents do not adversely affect the reaction, and may be halo, alkyl, alkoxy, haloalkyl, and nitro), or tertiary alkyl, for example, C(CH 3 ) 3 , C(CH ) 2 C(CH ) 2 , and
  • Step a is conducted in a preferably anhydrous, oxygen-free, aromatic solvent, for example, benzene, toluene, xylenes, or mixtures thereof.
  • a haloalkoxyarylhalide of Formula 1 is reacted with a hydrazone of Formula 1.1 in the presence of a palladium catalyst complex comprising palladium and a ligand, for example, tetrakis(triphenyl-phosphine)palladium(0) (Pd(PPh 3 ) 4 ) and tris(dibenzylideneacetone)dipalladium(0) (Pd 2 (dba) 3 ).
  • Palladium catalyst complexes can be made by known methods in the art, for example, the aforementioned palladium catalyst complexes can be prepared as in D.R. Coulson et al. Inorg. Synth. 1972, 13, 121, and L. Paquette, Encyclopedia of Reagents for Organic Synthesis 1996, Ed.: J. Wiley and Sons:shire, England, respectively; in general they can be made by reacting, for example:
  • a ligand for example:
  • Approximately a 1 : 1 molar ratio of the haloalkoxyarylhalide of Formula 1 and a hydrazone of Formula 1.1 may be used, however, molar ratios of about 1.5: 1 to about 1: 1.5 may also be used.
  • the reaction of the haloalkoxyarylhalide of Formula 1 with the hydrazine of Formula 1.1 is conducted in the presence of an organic base, for example, sodium iert-butoxide (NaO'Bu), potassium iert-butoxide (KO'Bu), and lithium hexamethyldisilazide (LiHMDS), an inorganic base, for example, sodium carbonate (Na 2 C0 3 ), potassium carbonate (K 2 C0 3 ), cesium carbonate (Cs 2 C0 3 ), and tripotassium phosphate (K P0 4 ), or mixtures thereof.
  • the reaction is conducted at a pH from about 8 to about 14 and preferably from about 12 to about 14.
  • the reaction is conducted at a temperature from about 20 °C to about 100 °C and preferably from about 95 °C to about 100 °C.
  • the reaction is conducted at about atmospheric pressure, however, higher or lower pressures can be used.
  • the hydrolysis conducted in step b is conducted in a polar, protic solvent, such as an alcohol, for example, methanol (MeOH) and ethanol (EtOH), in the presence of an aqueous inorganic acid, for example, hydrochloric acid (HC1), nitric acid (HN0 3 ), phosphoric acid (H 3 P0 4 ), sulphuric acid (H 2 S0 4 ), hydrofluoric acid (HF), hydrobromic acid (HBr), perchloric acid (HC10 4 ), tetrafluoroboric acid (HBF 4 ), or mixtures thereof.
  • the reaction is conducted at a pH from about -1 to about 4 and preferably from about -1 to about 1.
  • the reaction is conducted at a temperature from about 65 °C to about 85 °C and preferably from about 75 °C to about 80
  • step a benzonitriles of Formula 2.1 are reacted with anhydrous inorganic acids in an alcohol to produce said arylalkoxyimidate salts, wherein R 2 is (Ci-C6)alkyl.
  • Step a benzonitriles of Formula 2.1 are treated with an anhydrous inorganic acid (HX, wherein X is F, CI, Br, or I, preferably CI or Br), for example, HCl or HBr in a polar protic solvent, for example, an alcohol (R 2 OH), for example, MeOH, EtOH, w-butanol, isopropanol, or mixtures thereof.
  • HX gas is introduced directly into a solution of the benzonitrile of Formula 2.1 in R 2 OH via a sparge tube.
  • the reaction is conducted at a temperature from about -10 °C to about - 5 °C and preferably from about 0 °C to about - 5 °C during the HX sparge. It is preferred if the temperature is raised to about 25 °C following the addition of the HX.
  • HX gas may be introduced into the reaction system at pressures ranging from about atmospheric pressure to about 3500 kPa.
  • solutions of benzonitriles of Formula 2.1 in a variety of organic solvents, for example, tetrahydrofuran (THF), ethyl acetate (EtOAc), dichloromethane (CH 2 C1 2 ), toluene, or mixtures thereof, are treated with an anhydrous inorganic acid (HX), for example, HCl or HBr, in the presence of an alcohol (R 2 OH).
  • HX anhydrous inorganic acid
  • R 2 OH anhydrous inorganic acid
  • Molar ratios of benzonitriles of Formula 2.1 to the alcohol are from about 1 : 1 to about 1: 10, however, molar ratios of about 1: 1000 to about 1000: 1 may also be used.
  • HX is generated in situ via the decomposition of an acyl halide, such as, for example, acetyl chloride and acetyl bromide, when said acyl halide is contacted with R 2 OH.
  • acyl halide such as, for example, acetyl chloride and acetyl bromide
  • thionyl chloride is used as a source of HC1.
  • the acyl halide may be added to a solution of the benzonitrile of Formula 2.1 in R 2 OH or may be added to the R 2 OH first, followed by the addition of the benzonitrile of Formula 2.1 to the pre-formed solution of HX.
  • the reaction is conducted at a temperature from about -10 °C to about - 5 °C and preferably from about 0 °C to about - 5 °C during the HX formation, and preferably the temperature is raised to about 25 °C following the addition.
  • subjecting benzonitriles of Formula 2.1, wherein Ri is nitro or a benzoate ester, to one of the described methods affords alkoxyimidate salts of Formula 2.2, wherein Ri is as defined and R 2 is derived from R 2 OH.
  • subjecting benzonitriles of Formula 2.1, wherein Ri is a carboxylic acid to one of the described methods affords alkoxyimidate salts of Formula 2.2, wherein Ri is a mixture of the carboxylic acid and ester, wherein the Ri ester and R 2 are both derived from R 2 OH, e.g., when R 2 OH is MeOH, Ri is the methyl ester and R 2 is a methyl group.
  • 1,3-diaryltriazoles of Formula 3.2 can be prepared as illustrated in Scheme 3.
  • step a haloalkoxyarylhydrazine of Formula 1.3 is reacted with arylalkoxyimidate of Formula 2.2 to produce an intermediate iminohydrazine of Formula 3.1.
  • step b the iminohydrazine is cyclized using a formate source, such as, for example, formic acid, formate esters, such as methyl- and ethyl formate, and orthoesters, such as, trimethyl- and triethyl orthoformate, to afford said 1,3-diaryltriazoles of Formula 3.2.
  • a formate source such as, for example, formic acid, formate esters, such as methyl- and ethyl formate
  • orthoesters such as, trimethyl- and triethyl orthoformate
  • haloalkoxyarylhydrazine of Formula 1.3 and arylalkoxyimidate of Formula 2.2
  • step a solutions of arylalkoxyimidate salts of Formula 2.2 in a weakly alkaline, heterocyclic solvent, such as pyridine, lutidine, or mixtures thereof, or in a non-basic, polar, aprotic solvent such as, for example, acetonitrile (MeCN) and THF, in the presence of organic or inorganic bases are reacted with haloalkoxyarylhydrazine salts of Formula 1.3 to produce an intermediate iminohydrazine of Formula 3.1.
  • a weakly alkaline, heterocyclic solvent such as pyridine, lutidine, or mixtures thereof
  • a non-basic, polar, aprotic solvent such as, for example, acetonitrile (MeCN) and THF
  • organic and inorganic bases are pyridine, trialkylamines, such as, trimethylamine, triethylamine (TEA), and diisopropylethylamine (DIPEA), and alkali carbonates, such as, Na 2 C0 3 and K 2 C0 3 , respectively.
  • TAA triethylamine
  • DIPEA diisopropylethylamine
  • alkali carbonates such as, Na 2 C0 3 and K 2 C0 3 , respectively.
  • the reaction is conducted at a temperature from about -10 °C to about 10 °C and preferably from about 0 °C to about - 5 °C during the addition of the hydrazine, and then the temperature is preferably raised to about 25 °C following the addition.
  • step b the intermediate iminohydrazine of Formula 3.1 is cyclized using a formate source.
  • the reaction is conducted at a temperature from about 20 °C to about 100 °C and preferably from about 95 °C to about 100 °C, which effectively enables cyclization to form the 1,3-diaryltriazole of Formula 3.2.
  • 1,3-diaryl triazole compounds of Formula 4.2 and Formula 4.3 can be prepared according to Scheme 4.
  • intermediate 1,3-diaryltriazoles of Formula 3.2, wherein Ri is an ester can be saponified to give 1,3-diaryltriazoles substituted with a carboxylic acid of Formula 4.2.
  • intermediate 1,3-diaryltriazole of Formula 3.2), wherein Ri is nitro can be reduced to give 1,3-diaryltriazoles substituted with an amine of Formula 4.3.
  • Method a can be conducted in a polar, protic solvent, such as an alcohol, for example, MeOH, EtOH, w-butanol, isopropanol, or mixtures thereof, or in a polar, aprotic solvent such as THF, in the presence of an alkali hydroxide base, for example, sodium (NaOH), potassium (KOH), or lithium hydroxide (LiOH), and water.
  • a polar, protic solvent such as an alcohol, for example, MeOH, EtOH, w-butanol, isopropanol, or mixtures thereof
  • a polar, aprotic solvent such as THF
  • an alkali hydroxide base for example, sodium (NaOH), potassium (KOH), or lithium hydroxide (LiOH)
  • the reaction can be conducted at a temperature from about 20 °C to about 60 °C and preferably from about 20 °C to about 30 °C.
  • the pH of the reaction mixture is from about 8 to about 14
  • Method b can be carried out in a wide variety of organic solvents including, for example, polar, protic solvents, such as alcohols, e.g., MeOH, EtOH, w-butanol, isopropanol, or mixtures thereof, polar, aprotic solvents, such as THF and EtOAc, or organic acids, for example, acetic acid, in the presence of a catalyst, such as palladium on carbon or palladium hydroxide on carbon, preferably palladium hydroxide on carbon (10%), and a hydrogen source, for example hydrogen gas, ammonium salts, e.g., ammonium formate, and cyclohexadiene.
  • polar, protic solvents such as alcohols, e.g., MeOH, EtOH, w-butanol, isopropanol, or mixtures thereof
  • polar, aprotic solvents such as THF and EtOAc
  • organic acids for example, acetic acid
  • a catalyst
  • the reaction can be conducted at a temperature from about 20 °C to about 50 °C and preferably from about 20 °C to about 30 °C.
  • the reaction can be conducted at a pressure from about 101 kPa to about 689 kPa and preferably from about 101 to about 345 kPa. See also WO
  • 1,3-diaryltriazole of Formula 4.2 and Formula 4.3 can be used as intermediates to form pesticides disclosed in U.S. Patent No. 8,178,658 as disclosed therein.
  • Step 1 Preparation of l-(diphenylmethylene)-2-(4-(perfluoroethoxy)phenyl)-hydrazine: To a dry 2 L round bottomed flask fitted with an overhead mechanical stirrer, nitrogen inlet, thermometer, and reflux condenser were added 1 bromo-4-(perfluoroethoxy)-benzene (100 g, 344 mmol), benzophenone hydrazone (74.2 g, 378 mmol), and BINAP (4.28 g, 6.87 mmol), and the mixture was suspended in anhydrous toluene (500 mL).
  • Step 2 Preparation of (4-(perfluoroethoxy)phenyl)hydrazine hydrochloride: To a dry 250 mL round bottomed flask equipped with a magnetic stir bar, thermometer, and reflux condenser were added l-(diphenylmethylene)-2-(4-(perfluoroethoxy)phenyl)hydrazine (63.6 g, 157 mmol), EtOH (50 mL), and concentrated HC1 (100 mL, about 1.20 mol), and the reaction was warmed to 85 °C and stirred for 5 h. The reaction was cooled to room temperature and the dark slurry was concentrated to a brown paste on a rotary evaporator.
  • Step 1 Preparation of l-(diphenylmethylene)-2-(4-(perfluoroethoxy)phenyl)-hydrazine- 1:, N 2 : To a dry 250 mL round bottomed flask equipped with a magnetic stir bar, nitrogen inlet, and reflux condenser were added 1 bromo-4-(perfluoroethoxy)benzene (9.69 g, 33.3 mmol), benzophenone hydrazone- 15 N 2 (7.26 g, 36.6 mmol), and BINAP (0.415 g, 0.67 mmol), and the mixture was suspended in anhydrous toluene (35 mL).
  • Step 2 Preparation of (4-(perfluoroethoxy)phenyl)hydrazine hydrochloride- 15 N 2 : To a dry 250 mL round bottomed flask equipped with a magnetic stir bar, nitrogen inlet, and reflux condenser were added a solution of l-(diphenylmethylene)-2-(4-(perfluoroethoxy)- phenyl)hydrazine- 15 N 2 (8.98 g, 22.0 mmol) in EtOH (40 mL) followed by concentrated HCI (9 mL, about 108 mmol), and the reaction was warmed to 80 °C and stirred for 15 h.
  • the solid was dissolved in formic acid (20 mL) and the reaction was heated to 100 °C and stirred for 16 h. The reaction mixture was cooled to 28 °C and added to cold water (50 mL). The resulting precipitate was collected by vacuum filtration, washed with water, and dried.
  • Example 16 Preparation of (2 t S',3R,4R,5 t S',6 t S')-3,5-dimethoxy-6-methyl-4-propoxytetrahvdro- 2H-pyran-2-yl (4-( 1 -(4-(perfluoroethoxy)phenyl)- 1H- 1 ,2,4-triazol-( 1 ,2,4- 15 N 3- 13 C) 3- yPphenyPcarbamate:
  • Potassium phosphate (K P0 4; 0.045 g, 0.21 mmol) was added to the mixture followed by a solution of (2R,3R,4R,5 l S',6 l S , )-3,5-dimethoxy-6-methyl-4-propoxytetrahydro-2H-pyran-2-ol (0.275 g, 1.18 mmol), prepared as described by Crouse et. al. in WO 2009102736 Al, in CH 3 CN (2 mL) and DIPEA (0.276 g, 2.14 mmol), at which point the yellow-orange mixture became easier to stir.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

This document is related to the field of preparation of haloalkoxyarylhydrazines and certain intermediates derived therefrom, where said intermediates are useful in the preparation of certain pesticides disclosed in U.S. Patent No. 8,178,658.

Description

PREPARATION OF HALOALKOXYARYLHYDRAZINES
AND INTERMEDIATES THEREFROM
CROSS REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of U.S. Provisional Patent Application Serial No. 61/778,486 filed March 13, 2013, the entire disclosure of which is hereby expressly
incorporated by reference.
FIELD OF THE DISCLOSURE
This document is related to the field of preparation of haloalkoxyarylhydrazines and intermediates therefrom, where said intermediates are useful in the preparation of certain pesticides.
BACKGROUND OF THE DISCLOSURE
U.S. Patent No. 8,178,658 discloses pesticidal compositions comprising a compound having the following structure:
Formula A- 1
Figure imgf000002_0001
wherein Ar1; Het, Ar2, J, L, K, Q, Rl, R2, R3, and R4 are disclosed in the patent. While processes are disclosed on how to make such compounds, and such processes are useful, it is desired to have more useful processes to make these compounds. In particular, it is desirable to have more commercially useful routes to certain substituted triaryl intermediates disclosed in the patent that are useful in producing the compounds of Formula A- 1.
DESCRIPTION OF THE DISCLOSURE
Throughout this document, all temperatures are given in degrees Celsius, and all percentages are weight percentages unless otherwise stated.
The term "alkyl", as well as derivative terms such as "haloalkoxy", as used herein, include within their scope straight chain, branched chain and cyclic moieties. Thus, typical alkyl groups are methyl, ethyl, propyl, butyl, pentyl, hexyl, 1-methylethyl, 1,1-dimethylethyl, 1- methylpropyl, 2-methylpropyl, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. The term "haloalkoxy" includes alkoxy groups substituted with from one to the maximum possible number of halogen atoms, all combinations of halogens included. Unless specifically defined otherwise, the term "halogen" or "halo" includes fluorine, chlorine, bromine and iodine. Scheme 1
Figure imgf000003_0001
1 1.1 1.2 1.3
Haloalkoxyarylhydrazine salts ((HX)n where n = 0, 1, or 2) of Formula 1.3, wherein R is a (C1-C6)haloalkoxy, for example, trifluoromethoxy and pentafluoroethoxy, can be prepared as illustrated in Scheme 1. In general, in step a, a haloalkoxyarylhalide of Formula 1 (wherein X is F, CI, Br, or I, preferably Br) is reacted with a hydrazone of Formula 1.1 to give an intermediate haloalkoxyarylhydrazone of Formula 1.2; wherein Ri and R2 are independently aryl or heteroaryl, for example, phenyl, pyridyl, napthyl, and thienyl, substituted aryl or heteroaryl (wherein said substituents do not adversely affect the reaction, and may be halo, alkyl, alkoxy, haloalkyl, and nitro), or tertiary alkyl, for example, C(CH3)3, C(CH )2C(CH )2, and
C(CH )2C(CH ) . In step b, the intermediate hydrazone of Formula 1.2 is hydrolyzed to form said haloalkoxyarylhydrazine salts ((HX)n where n = 0, 1, or 2) of Formula 1.3.
Step a is conducted in a preferably anhydrous, oxygen-free, aromatic solvent, for example, benzene, toluene, xylenes, or mixtures thereof. A haloalkoxyarylhalide of Formula 1 is reacted with a hydrazone of Formula 1.1 in the presence of a palladium catalyst complex comprising palladium and a ligand, for example, tetrakis(triphenyl-phosphine)palladium(0) (Pd(PPh3)4) and tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3). Palladium catalyst complexes can be made by known methods in the art, for example, the aforementioned palladium catalyst complexes can be prepared as in D.R. Coulson et al. Inorg. Synth. 1972, 13, 121, and L. Paquette, Encyclopedia of Reagents for Organic Synthesis 1996, Ed.: J. Wiley and Sons: Sussex, England, respectively; in general they can be made by reacting, for example:
(a) palladium (II) acetate (Pd(OAc)2);
(b) palladium (II) chloride (PdCl2);
(c) sodium tetrachloropalladate (Na2PdCl4); and/or
(d) bis(dibenzylideneacetone) palladium(II) (Pd(dba)2),
with a ligand, for example:
(a) triphenylphosphine (PPh );
(b) l,l'-bis(diphenylphosphino)ferrocene (dppf); (c) dibenzylideneacetone (dba);
(d) 2'-bis(diphenylphosphino)-l,l'-binaphthyl (BINAP); and/or
(e) 2-dicyclohexylphosphino-2'-methylbiphenyl (MePhos).
Approximately a 1 : 1 molar ratio of the haloalkoxyarylhalide of Formula 1 and a hydrazone of Formula 1.1 may be used, however, molar ratios of about 1.5: 1 to about 1: 1.5 may also be used. The reaction of the haloalkoxyarylhalide of Formula 1 with the hydrazine of Formula 1.1 is conducted in the presence of an organic base, for example, sodium iert-butoxide (NaO'Bu), potassium iert-butoxide (KO'Bu), and lithium hexamethyldisilazide (LiHMDS), an inorganic base, for example, sodium carbonate (Na2C03), potassium carbonate (K2C03), cesium carbonate (Cs2C03), and tripotassium phosphate (K P04), or mixtures thereof. The reaction is conducted at a pH from about 8 to about 14 and preferably from about 12 to about 14. The reaction is conducted at a temperature from about 20 °C to about 100 °C and preferably from about 95 °C to about 100 °C. The reaction is conducted at about atmospheric pressure, however, higher or lower pressures can be used.
The hydrolysis conducted in step b is conducted in a polar, protic solvent, such as an alcohol, for example, methanol (MeOH) and ethanol (EtOH), in the presence of an aqueous inorganic acid, for example, hydrochloric acid (HC1), nitric acid (HN03), phosphoric acid (H3P04), sulphuric acid (H2S04), hydrofluoric acid (HF), hydrobromic acid (HBr), perchloric acid (HC104), tetrafluoroboric acid (HBF4), or mixtures thereof. The reaction is conducted at a pH from about -1 to about 4 and preferably from about -1 to about 1. The reaction is conducted at a temperature from about 65 °C to about 85 °C and preferably from about 75 °C to about 80
°C.
Intermediate haloalkoxyarylhydrazone of Formula 1.2 that are particularly preferred are
Figure imgf000004_0001
1-(diphenylmethylene)-2-(4-(perfluoroethoxy)phenyl)hydrazine
and
Figure imgf000005_0001
1 -(diphenylmethylene)-2-(4-(trifluoromethoxy)phenyl)hyd
Scheme 2
Figure imgf000005_0002
Arylalkoxyimidate salts of Formula 2.2, wherein Ri is N02, C(=0)OH or a (CrC6) ester thereof (C(=0)0(Ci-C6)alkyl), for example, methyl (C(=0)OCH3) or ethyl ester
(C(=0)OCH2CH3), can be prepared as outlined in Scheme 2. In step a, benzonitriles of Formula 2.1 are reacted with anhydrous inorganic acids in an alcohol to produce said arylalkoxyimidate salts, wherein R2 is (Ci-C6)alkyl.
In Step a benzonitriles of Formula 2.1 are treated with an anhydrous inorganic acid (HX, wherein X is F, CI, Br, or I, preferably CI or Br), for example, HCl or HBr in a polar protic solvent, for example, an alcohol (R2OH), for example, MeOH, EtOH, w-butanol, isopropanol, or mixtures thereof. In some embodiments, HX gas is introduced directly into a solution of the benzonitrile of Formula 2.1 in R2OH via a sparge tube. The reaction is conducted at a temperature from about -10 °C to about - 5 °C and preferably from about 0 °C to about - 5 °C during the HX sparge. It is preferred if the temperature is raised to about 25 °C following the addition of the HX. HX gas may be introduced into the reaction system at pressures ranging from about atmospheric pressure to about 3500 kPa. Alternatively, solutions of benzonitriles of Formula 2.1, in a variety of organic solvents, for example, tetrahydrofuran (THF), ethyl acetate (EtOAc), dichloromethane (CH2C12), toluene, or mixtures thereof, are treated with an anhydrous inorganic acid (HX), for example, HCl or HBr, in the presence of an alcohol (R2OH). Molar ratios of benzonitriles of Formula 2.1 to the alcohol are from about 1 : 1 to about 1: 10, however, molar ratios of about 1: 1000 to about 1000: 1 may also be used. In another embodiment, HX is generated in situ via the decomposition of an acyl halide, such as, for example, acetyl chloride and acetyl bromide, when said acyl halide is contacted with R2OH. In another embodiment thionyl chloride is used as a source of HC1. In this method the acyl halide may be added to a solution of the benzonitrile of Formula 2.1 in R2OH or may be added to the R2OH first, followed by the addition of the benzonitrile of Formula 2.1 to the pre-formed solution of HX. In both cases, the reaction is conducted at a temperature from about -10 °C to about - 5 °C and preferably from about 0 °C to about - 5 °C during the HX formation, and preferably the temperature is raised to about 25 °C following the addition.
In some embodiments, subjecting benzonitriles of Formula 2.1, wherein Ri is nitro or a benzoate ester, to one of the described methods affords alkoxyimidate salts of Formula 2.2, wherein Ri is as defined and R2 is derived from R2OH. In another embodiment, subjecting benzonitriles of Formula 2.1, wherein Ri is a carboxylic acid, to one of the described methods affords alkoxyimidate salts of Formula 2.2, wherein Ri is a mixture of the carboxylic acid and ester, wherein the Ri ester and R2 are both derived from R2OH, e.g., when R2OH is MeOH, Ri is the methyl ester and R2 is a methyl group.
Scheme 3
Figure imgf000006_0001
1.3 2.2 3.1 3.2
1,3-diaryltriazoles of Formula 3.2 can be prepared as illustrated in Scheme 3. In step a, haloalkoxyarylhydrazine of Formula 1.3 is reacted with arylalkoxyimidate of Formula 2.2 to produce an intermediate iminohydrazine of Formula 3.1. In step b, the iminohydrazine is cyclized using a formate source, such as, for example, formic acid, formate esters, such as methyl- and ethyl formate, and orthoesters, such as, trimethyl- and triethyl orthoformate, to afford said 1,3-diaryltriazoles of Formula 3.2. Optionally, haloalkoxyarylhydrazine of Formula 1.3 and arylalkoxyimidate of Formula 2.2 can be in the form of free bases.
In step a, solutions of arylalkoxyimidate salts of Formula 2.2 in a weakly alkaline, heterocyclic solvent, such as pyridine, lutidine, or mixtures thereof, or in a non-basic, polar, aprotic solvent such as, for example, acetonitrile (MeCN) and THF, in the presence of organic or inorganic bases are reacted with haloalkoxyarylhydrazine salts of Formula 1.3 to produce an intermediate iminohydrazine of Formula 3.1. Suitable examples of organic and inorganic bases are pyridine, trialkylamines, such as, trimethylamine, triethylamine (TEA), and diisopropylethylamine (DIPEA), and alkali carbonates, such as, Na2C03 and K2C03, respectively. The reaction is conducted at a temperature from about -10 °C to about 10 °C and preferably from about 0 °C to about - 5 °C during the addition of the hydrazine, and then the temperature is preferably raised to about 25 °C following the addition.
In step b, the intermediate iminohydrazine of Formula 3.1 is cyclized using a formate source. The reaction is conducted at a temperature from about 20 °C to about 100 °C and preferably from about 95 °C to about 100 °C, which effectively enables cyclization to form the 1,3-diaryltriazole of Formula 3.2.
Scheme 4
Figure imgf000007_0001
4.2 4.3
1,3-diaryl triazole compounds of Formula 4.2 and Formula 4.3 can be prepared according to Scheme 4. In method a, intermediate 1,3-diaryltriazoles of Formula 3.2, wherein Ri is an ester, can be saponified to give 1,3-diaryltriazoles substituted with a carboxylic acid of Formula 4.2. In method s, intermediate 1,3-diaryltriazole of Formula 3.2), wherein Ri is nitro, can be reduced to give 1,3-diaryltriazoles substituted with an amine of Formula 4.3.
Method a can be conducted in a polar, protic solvent, such as an alcohol, for example, MeOH, EtOH, w-butanol, isopropanol, or mixtures thereof, or in a polar, aprotic solvent such as THF, in the presence of an alkali hydroxide base, for example, sodium (NaOH), potassium (KOH), or lithium hydroxide (LiOH), and water. The reaction can be conducted at a temperature from about 20 °C to about 60 °C and preferably from about 20 °C to about 30 °C. The pH of the reaction mixture is from about 8 to about 14 and preferably from about 10 to about 12. Method b can be carried out in a wide variety of organic solvents including, for example, polar, protic solvents, such as alcohols, e.g., MeOH, EtOH, w-butanol, isopropanol, or mixtures thereof, polar, aprotic solvents, such as THF and EtOAc, or organic acids, for example, acetic acid, in the presence of a catalyst, such as palladium on carbon or palladium hydroxide on carbon, preferably palladium hydroxide on carbon (10%), and a hydrogen source, for example hydrogen gas, ammonium salts, e.g., ammonium formate, and cyclohexadiene. The reaction can be conducted at a temperature from about 20 °C to about 50 °C and preferably from about 20 °C to about 30 °C. The reaction can be conducted at a pressure from about 101 kPa to about 689 kPa and preferably from about 101 to about 345 kPa. See also WO
2009/102736 Al.
1,3-diaryltriazole of Formula 4.2 and Formula 4.3 can be used as intermediates to form pesticides disclosed in U.S. Patent No. 8,178,658 as disclosed therein.
EXAMPLES
These examples are for illustration purposes and are not to be construed as limiting the disclosure to only the embodiments disclosed in these examples.
Starting materials, reagents, and solvents that were obtained from commercial sources were used without further purification. Anhydrous solvents were purchased as Sure/Seal™ from Aldrich and were used as received. Melting points were obtained on a Thomas Hoover Unimelt capillary melting point apparatus or an OptiMelt Automated Melting Point System from Stanford Research Systems and are uncorrected. Examples using "room temperature" were conducted in climate controlled laboratories with temperatures ranging from about 20 °C to about 24 °C. Molecules are given their known names, named according to naming programs within ISIS Draw, ChemDraw or ACD Name Pro. If such programs are unable to name a molecule, the molecule is named using conventional naming rules. 1H NMR spectral data are in ppm (δ) and were recorded at 300, 400 or 600 MHz, and 13 C NMR spectral data are in ppm (□□ and were recorded at 75, 100 or 150 MHz, unless otherwise stated.
Exam le 1: Preparation of (4-(perfluoroethoxy)phenyl)hydrazine hydrochloride:
Figure imgf000008_0001
Step 1. Preparation of l-(diphenylmethylene)-2-(4-(perfluoroethoxy)phenyl)-hydrazine: To a dry 2 L round bottomed flask fitted with an overhead mechanical stirrer, nitrogen inlet, thermometer, and reflux condenser were added 1 bromo-4-(perfluoroethoxy)-benzene (100 g, 344 mmol), benzophenone hydrazone (74.2 g, 378 mmol), and BINAP (4.28 g, 6.87 mmol), and the mixture was suspended in anhydrous toluene (500 mL). To exclude oxygen, argon was sparged into the mixture for ten minutes (min) prior to and during the addition of Pd(OAc)2 (1.54 g, 6.87 mmol) and NaO'Bu (49.5 g, 515 mmol), which was added in portions. The argon sparge was halted and the brown mixture was warmed to 100 °C and stirred for 3 hours (h). The reaction was cooled to room temperature and poured into water (500 mL) and the aqueous mixture was extracted with EtOAc (3 x 200 mL). The combined organic extracts were washed with water, washed with saturated aqueous sodium chloride (NaCl), dried over anhydrous magnesium sulfate (MgS04), filtered, and concentrated under reduced pressure on a rotary evaporator. The crude product was purified by flash column chromatography using 0-100% (v/v) EtOAc/hexanes as eluent to give the title compound as a red oil (123.3 g, 88%): 1H NMR (400 MHz, CDC13) δ δ 7.63 - 7.56 (m, 4H), 7.55 (t, J = 1.5 Hz, 1H), 7.51 (d, J = 4.7 Hz, 1H), 7.36 - 7.26 (m, 5H), 7.13 - 7.04 (m, 4H); 19F NMR (376 MHz, CDC13) δ -85.94, -87.84; 13C NMR (101 MHz, CDC13) δ 145.23, 143.46, 141.24, 138.06, 132.53, 129.74, 129.41, 129.03, 128.30, 128.23, 126.57, 122.82, 113.45.
Step 2. Preparation of (4-(perfluoroethoxy)phenyl)hydrazine hydrochloride: To a dry 250 mL round bottomed flask equipped with a magnetic stir bar, thermometer, and reflux condenser were added l-(diphenylmethylene)-2-(4-(perfluoroethoxy)phenyl)hydrazine (63.6 g, 157 mmol), EtOH (50 mL), and concentrated HC1 (100 mL, about 1.20 mol), and the reaction was warmed to 85 °C and stirred for 5 h. The reaction was cooled to room temperature and the dark slurry was concentrated to a brown paste on a rotary evaporator. The paste was slurried in CH2C12 (200 mL) and the resulting solid was collected by vacuum filtration and dried under vacuum at 40 °C to give the title compound as a tan solid (36.0 g, 82%): 1H NMR (400 MHz, DMSO- 6) δ 10.47 (s, 3H), 8.62 (s, 1H), 7.43 - 7.18 (m, 2H), 7.20 - 6.93 (m, 2H); 19F NMR (376 MHz, DMSO- 6) δ -85.30, -87.02; ESIMS m/z 243.15 ([M+H]+).
Example 2: Preparation of (diphenylmethylene)hydrazine- N?:
Figure imgf000009_0001
To a 250 mL round bottom flask equipped with a magnetic stir bar, temperature probe, and reflux condenser were added benzophenone (9.0 g, 49.4 mmol), ethylene glycol (90 mL) and hydrazine monohydrate-15N2 (3.86 g, 74.1 mmol), and the mixture was warmed to 100 °C. The nearly homogeneous solution was stirred at 100 °C for 15 h and cooled to room
temperature. The resulting solid was collected by vacuum filtration, dissolved in EtOAc (80 mL), and washed with water (5 x 50 mL). The organic phase was dried over MgS04, filtered, and concentrated to a white/slightly yellow solid. The solid was dried under vacuum to give the title compound as a slightly yellow solid (7.26 g, 70%): mp 96 - 98 °C; 1H NMR (400 MHz, DMSO- 6) δ 7.57 (t, J = 1.4 Hz, 2H), 7.48 (dd, J = 10.6, 4.2 Hz, 1H), 7.38 - 7.18 (m, 7H), 6.34 (s, 1H), 6.14 (s, 1H); ESIMS mJz 199 ([M+H]+).
Example 3: Preparation of (4-(perfruoroethoxy)phenyl)hvdrazine hydrochloride- 15N?:
Figure imgf000010_0001
Step 1. Preparation of l-(diphenylmethylene)-2-(4-(perfluoroethoxy)phenyl)-hydrazine- 1:,N2: To a dry 250 mL round bottomed flask equipped with a magnetic stir bar, nitrogen inlet, and reflux condenser were added 1 bromo-4-(perfluoroethoxy)benzene (9.69 g, 33.3 mmol), benzophenone hydrazone-15N2 (7.26 g, 36.6 mmol), and BINAP (0.415 g, 0.67 mmol), and the mixture was suspended in anhydrous toluene (35 mL). To exclude oxygen, nitrogen was sparged into the mixture for 30 min prior to and during the addition of Pd(OAc)2 (0.149 g, 0.67 mmol) and NaO'Bu (4.80 g, 49.9 mmol), which was added in portions. The nitrogen sparge was halted and the brown mixture was warmed to 100 °C and stirred for 3 h. The reaction mixture was cooled to room temperature and stirred for 16 h, poured into water (35 mL), and the resulting aqueous mixture was extracted with EtOAc (3 x 35 mL). The combined organic extracts were washed with water, washed with brine, dried over MgS04, filtered, and
concentrated under reduced pressure on a rotary evaporator. The crude product was purified by flash column chromatography using 0- 10% EtOAc/hexanes as eluent to give the title compound as a yellow oil (8.98 g, 65%): 1H NMR (400 MHz, DMSO- 6) δ 9.14 (dd, J = 94.2, 2.3 Hz, 1H), 7.58 (dtt, J = 8.8, 5.7, 1.5 Hz, 3H), 7.45 (dd, J = 8.2, 1.3 Hz, 2H), 7.38 - 7.26 (m, 7H), 7.23 - 7.14 (m, 2H); 19F NMR (376 MHz, DMSO- 6) δ -85.30, -86.95; ESIMS mJz 409.11 ([M+H]+).
Step 2. Preparation of (4-(perfluoroethoxy)phenyl)hydrazine hydrochloride- 15N2: To a dry 250 mL round bottomed flask equipped with a magnetic stir bar, nitrogen inlet, and reflux condenser were added a solution of l-(diphenylmethylene)-2-(4-(perfluoroethoxy)- phenyl)hydrazine-15N2 (8.98 g, 22.0 mmol) in EtOH (40 mL) followed by concentrated HCI (9 mL, about 108 mmol), and the reaction was warmed to 80 °C and stirred for 15 h. The reaction was cooled to room temperature and the resulting tan solids were collected by vacuum filtration and washed on the filter with multiple portions of CH2CI2 to give a white solid (Crop 1). The filtrate was concentrated on a rotary evaporator and the residue was slurried in CH2CI2. The resulting solids were collected by vacuum filtration and washed as described above to give a white solid (Crop 2). Crops 1 and 2 were dried under vacuum and combined to give the title compound as a white solid (3.19 g, 52%): mp 217 - 223 °C; 1H NMR (400 MHz, DMSO- 6) δ 10.34 (s, 3H), 8.54 (d, J = 82.7 Hz, 1H), 7.29 (d, J = 8.9 Hz, 2H), 7.07 (dd, J = 8.9, 1.4 Hz, 2H); 19F NMR (376 MHz, DMSO- 6) δ -85.29, -87.00; ESIMS m/z 245.05 ([M+H]+).
Example 4: Preparation of methyl 4-(imino(methoxy)methyl)benzoate hydrochloride:
Figure imgf000011_0001
To a magnetically stirred solution of methyl 4-cyanobenzoate (12.5 g, 78 mmol) in benzene (25 mL) and MeOH (7 mL ) cooled to 0 °C was bubbled anhydrous HCl subsurface for 3 h. After storing in the refrigerator overnight, a heavy white precipitate formed. The solid was filtered through a fritted glass funnel and washed with diethyl ether to furnish the title compound as a white solid (17.5 g, 96 %): mp 209 - 210 °C; 1H NMR (400 MHz, CDC13) δ 13.05 (br s, 1H), 12.32 (br s, 1H), 8.48 (m, 2H), 8.22 (m, 2H), 4.60 (s, 3H), 3.97 (s, 3H); 13C NMR (101 MHz, DMSO- 6) δ 166.98, 165.69, 138.38, 131.74, 129.00, 127.78, 52.29, 26.16; EIMS m/z 192 ([M+]).
Example 5: Preparation of methyl 4-(ethoxy(imino)methyl)benzoate hydrochloride
Figure imgf000011_0002
A 2 L, three-necked round bottomed flask equipped with a magnetic stir bar, a temperature probe, addition funnel and nitrogen inlet was charged with methyl 4-cyanobenzoate (100 g, 620 mmol). The methyl 4-cyanobenzoate was dissolved in EtOH (438 mL) and cooled in an ice bath to 0 °C. Acetyl chloride (353 mL, 4960 mmol) was added dropwise into the stirring solution over a 2 h period during which time an exotherm from 0 °C to 21 °C was noted. The reaction flask was capped, sealed with Parafilm®, and allowed to stir at 23 °C for 18 h. The resulting white solid was collected by vacuum filtration and washed with EtOH. The filtrate was concentrated until it became turbid and was then cooled to 23 °C. The resulting precipitate was collected by vacuum filtration, rinsed with EtOH, and the filtrate treated as described to give another crop. The solids were dried to give the title compound as a white solid (128 g, 85%): 1H NMR (400 MHz, CDC13) δ 12.85 (br s, 1H), 12.20 (br s, 1H), 8.49 (m, 2H), 8.23 (m, 2H), 5.00 (q, 2H), 4.00 (s, 3H), 1.72 (t, 3H).
Example 6: Preparation of 4-(ethoxy(imino)methyl)benzoic acid hydrochloride and ethyl 4-
(ethoxy(imino)methyl)benzoate hydrochloride
Figure imgf000012_0001
A 500 mL, three-necked flask, equipped with a magnetic stir bar, nitrogen inlet, addition funnel, and a temperature probe was charged with anhydrous EtOH (125 mL). The vessel was cooled to 5 °C and acetyl chloride (97 mL, 1332 mmol) was added at a rate that maintained the temperature range of 5 °C to about 10 °C. When the addition was complete, 4-cyanobenzoic acid (25 g, 167 mmol) was added in portions over 15 min. No exotherm was noted during the addition of the solid. When the addition was complete, the white suspension was allowed to warm to 25 °C. The reaction vessel was sealed with Parafilm® and stirred at 23 °C for 18 h. The white suspension was vacuum filtered and the solid was rinsed with EtOH and dried to constant mass, furnishing 4-(ethoxy(imino)methyl)benzoic acid hydrochloride as a white solid (25 g, 65%): 1H NMR (400 MHz, DMSO- 6) δ 12.44 (br s, 1H), 8.26 (m, 2H), 8.14 (m, 2H), 4.70 (q, 2H), 1.51 (t, 3H).
The filtrate was concentrated and treated with ether to give a white solid. The solid was collected by vacuum filtration and rinsed with ether to give ethyl 4- (ethoxy(imino)methyl)benzoate hydrochloride as a white solid (11 g, 25%): 1H NMR (400 MHz, DMSO- 6) δ 12.07 (br s, 1H), 8.24 (m, 2H), 8.15 (m, 2H), 4.66 (q, 3H), 4.37 (q, 3H), 1.49 (t, 3H), 1.35 (q, 3H).
Example 7: Preparation of ethyl 4-nitrobenzimidate hydrochloride
Figure imgf000013_0001
To a solution of 4-nitrobenzonitrile (27 g, 182 mmol) in EtOH (128 ml, 2187 mmol) under nitrogen was added acetyl chloride (104 ml, 1458 mmol) dropwise at 0 °C over 1 h, and the reaction was warmed to room temperature. The flask was sealed and the reaction was stirred for 56 h. The resulting precipitate (4-nitrobenzamide) was collected by filtration, and the filtrate was treated with diethyl ether. The resulting precipitate was collected by filtration, washed with diethyl ether and air dried to give the title compound (26.7 g, 58%): mp 198 - 200 °C; 1H NMR (400 MHz, DMSO- 6) δ 8.37 - 8.30 (m, 2H), 8.21 - 8.13 (m, 2H), 7.35 (s, 1H), 7.22 (s, 1H), 7.09 (s, 1H), 4.34 (q, J = 7.1 Hz, 2H), 1.32 (t, J = 7.1 Hz, 3H); EIMS m/z 193.
13 15
Example 8: Preparation of ethyl 4-nitrobenzimidate hydrochloride- C N
I
Figure imgf000013_0002
To a 100 mL round bottomed flask equipped with a magnetic stir bar, temperature probe, nitrogen inlet, and liquid addition funnel was added anhydrous EtOH (5 mL) and the EtOH was cooled to 0 °C and treated dropwise with acetyl chloride (8.37 g, 107 mmol). To the
13 15 resulting solution of HCI in EtOH was added a solution of 4-nitrobenzonitrile- C, N (2.0 g, 13.3 mmol) in EtOH (10 mL) dropwise between 0 °C and 8 °C. The reaction mixture was warmed to room temperature and the flask was sealed with stoppers and Parafilm ® and the contents were stirred for 17 h. The resulting precipitate was collected by filtration and washed with diethyl ether and EtOH, and the filtrate was treated with diethyl ether. The resulting precipitate was collected by filtration, washed with diethyl ether and air dried (repeated 2 x) to give the title compound as a pale-yellow solid (2.20 g, 71%): mp 198 - 200 °C; 1H NMR (400 MHz, DMSO- 6) δ 12.87 - 11.58 (m, 1H), 8.43 (d, / = 8.6 Hz, 2H), 8.33 (ddd, / = 10.9, 5.0, 3.2 Hz, 2H), 4.65 (qd, / = 6.9, 2.0 Hz, 2H), 1.49 (t, / = 7.0 Hz, 3H).
Figure imgf000014_0001
To a magnetically stirred solution of methyl 4-(imino(methoxy)methyl)benzoate hydrochloride (1.15 g, 5.00 mmol) in anhydrous pyridine (5 mL) cooled by an ice bath was added (4-(trifluoromethoxy)phenyl)hydrazine hydrochloride (1.14 g, 5.00 mmol) in several portions. After warming to room temperature overnight (18 h), the yellow reaction mixture was diluted with water (25 mL) and washed with CH2CI2 (2 x 50 mL). The combined organic layers were washed with brine, dried over MgS04, filtered, and concentrated to give an orange-yellow solid (1.60 g). The solid was dissolved in formic acid (15 mL), warmed to reflux, and stirred at reflux for 8 h. The reaction mixture was cooled to room temperature, diluted with water, and washed with diethyl ether (2 x 50 mL). The combined diethyl ether washes were washed with water (3 x 50 mL), washed with brine (50 mL), dried over MgS04, filtered, and concentrated on a rotary evaporator to give the title compound (1.42 g, 78%) as a tan solid. A sample was purified for analytical characterization by flash column chromatography using 0- 100%
EtOAc/hexanes (v/v) as eluent to give the product as an off-white solid: mp 171 - 172 °C; 1H NMR (400 MHz, CDC13) δ 8.60 (s, 1H), 8.27 (m, 2H), 8.15 (m, 2H), 7.81 (m, 2H), 7.40 (d, J = 8.5 Hz, 2H), 3.95 (s, 3H); 13C NMR (101 MHz, CDC13) δ 166.76, 162.61, 148.55, 141.77, 135.41, 134.46, 131.03, 130.02, 126.46, 122.44, 121.66, 121.31, 119.10; ESIMS m/z 363 ([M+]).
Example 10: Preparation of 4-(l-(4-(perfluoroethoxy)phenyl)- lH-L2,4-triazol-3-yl)benzoic acid:
Figure imgf000014_0002
A I L, three-neck round bottomed flask, equipped with an overhead mechanical stirrer, temperature probe, and nitrogen inlet was charged with 4-(ethoxy(imino)methyl)benzoic acid hydrochloride (25 g, 109 mmol) and pyridine (200 mL). The white suspension was cooled to 5 °C in an ice bath and (4-(perfluoroethoxy)phenyl)hydrazine hydrochloride (30.9 g, 109 mmol) was added in portions. The white suspension turned yellow and the temperature rose to 5.7 °C. The ice bath was removed and the reaction mixture was allowed to warm slowly. At about 12 °C, the contents of the flask became too thick to stir. Additional pyridine (20 mL) was added and warming continued for 20 min. The reaction mixture was poured into water (400 mL) resulting in precipitation of a flocculent solid. The mixture was extracted with CH2CI2 (1 x 400 mL) and the phases were separated. The residual solid floating on top of the aqueous layer was collected by vacuum filtration and washed with CH2CI2, and the aqueous filtrate was extracted with CH2CI2 (2 x 200 mL). The organic extracts and washes were combined, washed with water (2 x 500 mL), and the water washes were back-extracted with CH2CI2 until the aqueous layer was colorless (1 x 200 mL). The organic extracts were concentrated under reduced pressure to yield a dark, red oil (17.2 g). The previously isolated solid was suspended in CH2CI2 (500 mL), stirred for 5 min, collected by filtration, rinsed on the filter with CH2CI2, and dried under vacuum at 50 °C to give a bright yellow solid (20 g).
A 500 mL, three-necked, round bottomed flask, fitted with a magnetic stir bar, temperature probe, and nitrogen inlet, was charged with the dark red oil (17.2 g) and the bright yellow solid (20 g) isolated above. Formic acid (200 mL) was added and the mixture was heated to 100 °C and stirred for 16 h. The heat was removed and the mixture was allowed to cool. The mixture was cooled to 23 °C (precipitate forms at about 90 °C) and water (200 mL) was added. The mixture was stirred for 1 h and the solid was collected by vacuum filtration, washed with water, air dried, and then dried under vacuum at 50 °C for 2 days (d) to furnish the title compound as a light tan solid (22.3 g, 51%): 1H NMR (400 MHz, DMSO- 6) δ 13.13 (s, 1H), 9.48 (s, 1H), 8.23 (m, 2H), 8.10 (m, 4H), 7.64 (m, 2H). Example 11 : Preparation of 3-(4-nitrophenyl)- l-(4-(perfluoroethoxy)phenyl)- lH-l,2,4-triazole:
Figure imgf000016_0001
To a stirred solution of ethyl 4-nitrobenzimidate hydrochloride (3 g, 13 mmol) in pyridine (13 mL) at 0 °C was added (4-(perfluoroethoxy)phenyl)hydrazine hydrochloride (3.62 g, 13.0 mmol) in three portions. The reaction mixture was warmed to room temperature and stirred for 2 h and was diluted with water and CH2CI2. The phases were separated and the aqueous layer was extracted with CH2CI2 (3 x 20 mL), and the combined organic fractions were washed with water (30 mL), dried over MgS04, and filtered. Concentration of the filtrate afforded a sticky red solid: 1H NMR (400 MHz, CDC13) δ 8.34 - 8.23 (m, 2H), 8.00 - 7.90 (m, 2H), 7.20 - 7.07 (m, 4H), 6.33 (s 1H), 4.66 (s, 2H); ESIMS mJz 390 ([M]+).
The solid was added to formic acid (30 mL) and the reaction was heated to 100 °C and stirred for 18 h. The reaction mixture was cooled to room temperature and added to cold water. The resulting precipitate was collected by vacuum filtration, washed with water, and dried under vacuum to give the title compound as a light pink solid (4.99 g, 96%): mp 132 - 135 °C; 1H NMR (400 MHz, CDC13) δ 8.68 (s, 1H), 8.43 - 8.31 (m, 4H), 7.89 - 7.80 (m, 2H), 7.49 - 7.38 (m, 2H); ESIMS m/z 400 ([M]+).
Example 12: Preparation of 3-(4-nitrophenyl)- l-(4-(perfluoroethoxy)phenyl)- lH- l,2,4-triazole-
Figure imgf000016_0002
To a stirred solution of ethyl 4-nitrobenzimidate hydrochloride- C- N (2.13 g, 9.18 mmol) in pyridine (10 mL) at 0 °C was added (4-(perfluoroethoxy)phenyl)hydrazine hydrochloride- 15N2 (2.57 g, 9.18 mmol) in portions. The reaction mixture was warmed to room temperature and stirred for 3 h and was diluted with water (20 mL) and CH2CI2 (20 mL). The phases were separated and the aqueous layer was extracted with CH2CI2 (3 x 20 mL), and the combined organic fractions were washed with water (2 x 40 mL), dried over MgS04, and filtered. Concentration of the filtrate afforded a sticky red solid.
The solid was dissolved in formic acid (20 mL) and the reaction was heated to 100 °C and stirred for 16 h. The reaction mixture was cooled to 28 °C and added to cold water (50 mL). The resulting precipitate was collected by vacuum filtration, washed with water, and dried. The crude product was purified by flash column chromatography using 0-60% EtOAc/hexanes (v/v) to give the title compound as a light tan solid (1.1 g, 30%): mp 133 - 136 °C; 1H NMR (400 MHz, DMSO- 6) δ 9.51 (td, J = 11.9, 8.9 Hz, 1H), 8.34 (ddd, J = 9.0, 6.6, 5.3 Hz, 4H), 8.15 - 8.06 (m, 2H), 7.63 (d, J = 8.9 Hz, 2H); ESIMS m/z 405 ([M+H]+).
Example 13: Preparation of 4-(l-(4-(trifluoromethoxy)phenyl)-lH- L2,4-triazol-3-yl)benzoic acid:
Figure imgf000017_0001
To a solution of methyl 4-(l-(4-(trifluoromethoxy)phenyl)- lH-l,2,4-triazol-3- yl)benzoate (0.332 g, 0.914 mmol) in THF (6 mL) and water (3 mL) was added LiOH (0.066 g, 2.74 mmol), and the solution immediately turned from yellow to orange-red. The reaction was stirred vigorously at room temperature for 16 h. The solution was acidified to pH 2 and diluted with water and CH2CI2. The phases were separated and the aqueous layer was extracted with EtOAc (3 x 10 mL) and the combined organic fractions were washed with water (10 mL), washed with brine (10 mL), dried over MgS04, filtered, and concentrated to give the title compound as a tan solid (0.29 g, 91%): mp 228 - 233 °C; 1H NMR (400 MHz, DMSO-d6) δ 10.55 - 10.24 (m, 1H), 9.46 (s, 1H), 8.23 (d, J = 8.0 Hz, 2H), 8.09 (d, J = 1.9 Hz, 4H), 7.64 (d, J = 8.5 Hz, 2H); ESIMS m/z 350 ([M+H]+). Example 14. Preparation of 4-(l-(4-(perfluoroethoxy)phenyl)-lH-l,2,4-triazol-3-yl)benzoic acid Alternative to Example 10):
Figure imgf000018_0001
In a 250 mL round bottomed flask equipped with an overhead stirrer, T-type thermocouple, and nitrogen inlet were added methyl 4-(l-(4-(perfluoroethoxy)phenyl)-lH- l,2,4-triazol-3-yl)benzoate (11.1 g, 26.9 mmol) and THF (100 mL). To this yellow suspension were added water (10 mL) and lithium hydroxide- monohydrate (LiOH H20; 3.4 g, 81 mmol). The reaction was stirred at 23 °C for 39 h during which time it became a yellow solution. The solution was warmed to 60 °C and stirred at 60 °C until complete by LC-MS. The reaction was cooled to 4 °C in an ice bath and water (100 mL) was added to give a light yellow solution. Concentrated HC1 (8.0 g) was added (note: exothermic) resulting in a thick white precipitate. The white suspension was stirred at 5 °C for 30 min and then the solid was collected by vacuum filtration. The filter cake was washed with water (2 x 25 mL), air dried for 3 h, and dried under vacuum (700 mm Hg) at 50 °C for 16 h to give the title compound as a white solid (10.3 g, 96%): mp 227 - 229 °C; 1H NMR (400 MHz, CDC13) δ 8.65 (s, 1H), 8.32 (d, J = 8.4 Hz, 2H), 8.23 (d, J = 8.4 Hz, 2H), 7.84 (d, J = 8.9 Hz, 1H), 7.42 (d, J = 8.9 Hz, 2H).
Example 15: Preparation of 4-(l-(4-(perfluoroethoxy)phenyl)- lH-L2,4-triazol-(L2,4-
Figure imgf000018_0002
To a magnetically stirred solution of 3-(4-nitrophenyl)-l-(4-(perfluoroethoxy)phenyl)- lH-l,2,4-triazole-l,2,4-15N3-3-13C (1.1 g, 2.72 mmol) in EtOAc (40 mL) was added palladium on carbon (10 % wt, 110 mg), and the reaction flask was evacuated and purged with hydrogen (Repeated 4x). The reaction mixture was placed under an hydrogen atmosphere (balloon) and stirred at room temperature for 2.5 h. The mixture was filtered through Celite® and concentrated on a rotary evaporator to give the title compound as a white solid (0.92 g, 90%): mp 177 - 180 °C; 1H NMR (400 MHz, DMSO- 6) δ 9.28 (td, J = 11.8, 8.9 Hz, 1H), 8.11 - 8.01 (m, 2H), 7.86 - 7.75 (m, 2H), 7.59 (d, J = 8.9 Hz, 2H), 6.66 (d, J = 8.3 Hz, 2H), 5.51 (s, 2H); ESIMS m/z 375 ([M+H]+).
Example 16: Preparation of (2tS',3R,4R,5tS',6tS')-3,5-dimethoxy-6-methyl-4-propoxytetrahvdro- 2H-pyran-2-yl (4-( 1 -(4-(perfluoroethoxy)phenyl)- 1H- 1 ,2,4-triazol-( 1 ,2,4- 15N 3- 13C) 3- yPphenyPcarbamate:
Figure imgf000019_0001
To a magnetically stirred solution of 4-(l-(4-(perfluoroethoxy)phenyl)-lH-l,2,4-triazol- (l,2,4-15N3-3-13C)-3-yl)aniline (0.400 g, 1.07 mmol) in anhydrous MeCN (10 mL) was added 4- nitrophenylchloroformate (0.215 g, 1.07 mmol) and within min a white precipitate formed. The thick mixture was stirred for 1 h, at which time HPLC-MS analysis indicated full conversion of the aniline starting material to the desired carbamate (ESIMS m/z 540 ([M+H]+). Potassium phosphate (K P04; 0.045 g, 0.21 mmol) was added to the mixture followed by a solution of (2R,3R,4R,5lS',6lS,)-3,5-dimethoxy-6-methyl-4-propoxytetrahydro-2H-pyran-2-ol (0.275 g, 1.18 mmol), prepared as described by Crouse et. al. in WO 2009102736 Al, in CH3CN (2 mL) and DIPEA (0.276 g, 2.14 mmol), at which point the yellow-orange mixture became easier to stir. The reaction was stirred for 16 h at room temperature, concentrated on a rotary evaporator, and the yellow-brown residue was partitioned between EtOAc (20 mL) and water (20 mL). The phases were separated and the organic phase was washed with water (2 x 20 mL), washed with brine (20 mL), dried over MgS04, filtered, and the filtrate concentrated to give the crude product as a yellow-brown foam. The foam was purified by reverse phase column chromatography (CI 8) using 5-95% MeCN/water (0.1% trifluoroacetic acid (TFA) as eluent to give an oily, yellow foam (isolated 115 mg). The residual foam that could not be scraped from the flask (180 mg) was treated with heptane (3 mL) and warmed to 80 °C. After stirring for ~5 min the foam had transformed into a solid. The solid was collected by vacuum filtration and dried to give the title compound as a tan solid (0.261 g total, 38%): mp 142 - 146 °C; 1H NMR (400 MHz, CDC13) δ 8.59 (td, J = 11.6, 8.7 Hz, 1H), 8.20 - 8.13 (m, 2H), 7.86 - 7.77 (m, 2H), 7.54 (d, J = 8.0 Hz, 2H), 7.40 (d, J = 8.9 Hz, 2H), 6.85 (s, 1H), 6.20 (d, J = 1.8 Hz, 1H), 3.77 - 3.49 (m, 11H), 3.21 (t, J = 9.4 Hz, 1H), 1.68 (dd, J = 14.1, 7.3 Hz, 2H), 1.34 (t, J = 8.7 Hz, 3H), 0.98 (dd, J = 9.5, 5.3 Hz, 3H); ESIMS m/z 635 ([M+H]+).

Claims

WHAT IS CLAIMED IS:
1. A process comprising:
Figure imgf000021_0001
1.1 1.2 1.3
(la) reacting a haloalkoxyarylhalide of Formula 1 with a hydrazone of Formula 1.1 in the presence of a palladium catalyst complex comprising palladium and a ligand to produce an intermediate haloalkoxyarylhydrazone of Formula 1.2; followed by
(lb) hydrolyzing said intermediate haloalkoxyarylhydrazone of Formula 1.2 to produce a haloalkoxyarylhydrazine of Formula 1.3; wherein R is a (Ci-C6)haloalkoxy; X is F, CI, Br, or I; n = 0, 1, or 2; wherein Ri and R2 are independently aryl, heteroaryl, substituted aryl, substituted heteroaryl, or tertiary alkyl, wherein the substituents do not adversely affect the reaction.
2. A process according to claim 1 further comprising:
Figure imgf000021_0002
1.3 2.2 3.1 3.2
(2a) reacting said haloalkoxyarylhydrazine of Formula 1.3 with an arylalkoxyimidate of Formula 2.2 to produce an intermediate iminohydrazine of Formula 3.1; followed by (2b) cyclizing said intermediate iminohydrazine of Formula 3.1 using a formate source to produce a 1,3-diaryltriazole of Formula 3.2; wherein R4 is N02, C(=0)OH, or C(=0)0(C1-C6)alkyl; and R3 is (C1-C6)alkyl.
3. A process according to claim 1 wherein (la) R is trifluoromethoxy or
pentafluoroethoxy.
4. A process according to claim 1 wherein (la) X is Br.
5. A process according to claim 1 wherein (la) R and R2 are phenyl.
6. A process according to claim 1 wherein (la) palladium catalyst complex is
tetrakis(triphenyl-phosphine)palladium(0), tris(dibenzylideneacetone)dipalladium(0)
(Pd2(dba)3), or is prepared in situ by contacting palladium (Π) acetate (Pd(OAc)2); palladium (II) chloride (PdCl2), sodium tetrachloropalladate (Na2PdCl4); bis(dibenzylideneacetone) palladium(II) (Pd(dba)2), with a ligand, selected from triphenylphosphine (PPh ),l,l'- bis(diphenylphosphino)ferrocene (dppf), dibenzylideneacetone (dba); 2'- bis(diphenylphosphino)-l,l'-binaphthyl (BINAP); or2-dicyclohexylphosphino-2'- methylbiphenyl (MePhos).
7. A process according to claim 1 wherein (la) a molar ratio of the haloalkoxyarylhalide of Formula 1 and a hydrazone of Formula 1.1 is from about 1.5: 1 to about 1: 1.5.
8. A process according to claim 1 wherein (la) the reaction of the haloalkoxyarylhalide of Formula 1 with the hydrazine of Formula 1.1 is conducted in the presence of sodium tert- butoxide (NaO'Bu), potassium iert-butoxide (KO'Bu), lithium hexamethyldisilazide (LiHMDS), sodium carbonate (Na2C03), potassium carbonate (K2C03), cesium carbonate (Cs2C03), tripotassium phosphate (K P04), or mixtures thereof.
9. A process according to claim 1 wherein (la) the pH is from about 12 to about 14.
10. A process according to claim 1 wherein (la) the temperature from about 95 - 100 °C.
11. A process according to claim 1 wherein (lb) is conducted in methanol or ethanol.
12. A process according to claim 1 wherein (lb) the pH is from about -1 to about 1.
13. A process according to claim 2 wherein (2a) is conducted in pyridine, lutidine, or mixtures thereof.
14. A process according to claim 2 wherein (2b) is conducted at a temperature from about 95 to about 100 °C.
15. A process according to claim 2 wherein (2b) formate source is formic acid.
16. A process according to claim 2 wherein: R is pentafluoroethoxy; and R4 is N02, C(=0)OH, C(=0)OCH3, or C(=0)OCH2CH3.
17. A process according to claim 2 wherein (la) R is trifluoromethoxy or
pentafluoroethoxy.
18. A process according to claim 2 wherein (la) X is Br.
19. A process according to claim 2 wherein (la) R and R2 are phenyl.
20. A process according to claim 2 wherein (la) palladium catalyst complex is
tetrakis(triphenyl-phosphine)palladium(0), tris(dibenzylideneacetone)dipalladium(0)
(Pd2(dba)3), or is prepared in situ by contacting palladium (Π) acetate (Pd(OAc)2); palladium (II) chloride (PdCl2), sodium tetrachloropalladate (Na2PdCl4); bis(dibenzylideneacetone) palladium(II) (Pd(dba)2), with a ligand, selected from triphenylphosphine (PPh ),l,l'- bis(diphenylphosphino)ferrocene (dppf), dibenzylideneacetone (dba); 2'- bis(diphenylphosphino)-l,l'-binaphthyl (BINAP); or2-dicyclohexylphosphino-2'- methylbiphenyl (MePhos).
21. A process according to claim 2 wherein (la) a molar ratio of the haloalkoxyarylhalide of Formula 1 and a hydrazone of Formula 1.1 is from about 1.5: 1 to about 1: 1.5.
22. A process according to claim 2 wherein (la) the reaction of the haloalkoxyarylhalide of Formula 1 with the hydrazine of Formula 1.1 is conducted in the presence of sodium tert- butoxide (NaO'Bu), potassium iert-butoxide (KO'Bu), lithium hexamethyldisilazide (LiHMDS), sodium carbonate (Na2C03), potassium carbonate (K2C03), cesium carbonate (Cs2C03), tripotassium phosphate (K P04), or mixtures thereof.
23. A process according to claim 2 wherein (la) the pH is from about 12 to about 14.
24. A process according to claim 2 wherein (la) the temperature from about 95 - 100 °C.
25. A process according to claim 2 wherein (lb) is conducted in methanol or ethanol.
26. A process according to claim 2 wherein (lb) the pH is from about -1 to about 1.
27. Intermediate haloalkoxyarylhydrazones of Formula 1.2 having the following structures
Figure imgf000024_0001
1-(diphen lmethylene)-2-(4-(perfluoroethoxy)phenyl)hydrazine
and
Figure imgf000024_0002
1-(diphenylmethylene)-2-(4-(trifluoromethoxy)phenyl)hydrazine
PCT/US2014/018981 2013-03-13 2014-02-27 Preparation of haloalkoxyarylhydrazines and intermediates therefrom Ceased WO2014158641A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361778486P 2013-03-13 2013-03-13
US61/778,486 2013-03-13

Publications (1)

Publication Number Publication Date
WO2014158641A1 true WO2014158641A1 (en) 2014-10-02

Family

ID=51530150

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/018981 Ceased WO2014158641A1 (en) 2013-03-13 2014-02-27 Preparation of haloalkoxyarylhydrazines and intermediates therefrom

Country Status (3)

Country Link
US (1) US20140275558A1 (en)
AR (1) AR094950A1 (en)
WO (1) WO2014158641A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025240823A1 (en) * 2024-05-16 2025-11-20 Corteva Agriscience Llc Processes related to preparation of triazole derivatives

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943583A (en) * 1986-12-01 1990-07-24 Hoffmann-La Roche Inc. Heterocyclic compounds
US6489512B1 (en) * 2002-06-21 2002-12-03 Rhodia Chirex Inc. Method for making aryl hydrazines and substituted indoles

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943583A (en) * 1986-12-01 1990-07-24 Hoffmann-La Roche Inc. Heterocyclic compounds
US6489512B1 (en) * 2002-06-21 2002-12-03 Rhodia Chirex Inc. Method for making aryl hydrazines and substituted indoles

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZARGUIL, A. ET AL.: "Easy access to triazoles, triazolopyrimidines, benzimidazoles and imidazoles from imidates.", TETRAHEDRON LETTERS, vol. 49, no. 41, 2008, pages 5883 - 5886 *

Also Published As

Publication number Publication date
AR094950A1 (en) 2015-09-09
US20140275558A1 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
US9108932B2 (en) Preparation of haloalkoxyarylhydrazines and intermediates therefrom
JP7759167B2 (en) Process for the preparation of 1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]pyrazole-4-carboxamide
JP2008174547A (en) Method for producing asenapine synthetic intermediate
WO2010122794A1 (en) Process for production of pyrazinecarboxylic acid derivative, and intermediate for the production
KR101728443B1 (en) Method for Producing Benzyl Ester 2-aminonicotinicotinate Derivative
US20140275563A1 (en) Preparation of 1,3-(substituted-diaryl)-1,2,4-triazoles and intermediates therefrom
WO2014158641A1 (en) Preparation of haloalkoxyarylhydrazines and intermediates therefrom
WO2014158639A1 (en) Preparation of certain (substituted-phenyl)-triazolyl-(substituted phenyl) molecules, and intermediates and insecticides related thereto
JP6943560B2 (en) Method for Producing 2-Amino-6-Methylnicotinic Acid Ester or Protonate thereof
JP4879907B2 (en) Process for producing phenyl 2-pyrimidinyl ketones and novel intermediates thereof
US9376401B2 (en) Preparation of 1,3-(substituted-diaryl)-1,2,4-triazoles and intermediates therefrom
JP5205971B2 (en) Method for producing tetrahydropyran compound
KR20150088734A (en) Process for the preparation of bis[4-(6-acryloyloxyhexyl)phenyl] cyclohexane-1,4-dicarboxylate
JP2011057575A (en) Manufacturing method of 4-hydroxybenzothiophene derivative
JP2009040763A (en) Method for producing silanol compound
JP2004244362A (en) Method for producing 1,2-disubstituted-1,4-dihydro-oxoquinoline derivative
JP3526606B2 (en) Method for producing N-substituted pyrazinecarboxamides
JP2018087142A (en) Method for producing 3-halogenated alkylpyrazole derivative
KR101085202B1 (en) Method for preparing α-keto (cyanomethylene) triphenylphosphorane compound from brominated alkyl compounds
WO2014158638A1 (en) Preparation of certain (substituted phenyl)-triazolyl-(substituted phenyl) molecules, and intermediates and insecticides related thereto
JP2020158499A (en) Manufacturing method of isatin derivative
JP2009046400A (en) Intermediate for producing insecticidal compound and method for producing the same
US20140275560A1 (en) Preparation of 1,3-(substituted-diaryl)-1,2,4-triazoles and intermediates therefrom
JP2002201169A (en) Method for producing 4-cyano-3-oxobutanoic acid ester
JP2008001662A (en) Novel synthesis of 2-acylaminoimidazole-4-aldehyde derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14772831

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14772831

Country of ref document: EP

Kind code of ref document: A1